Search research articles
Contact Us
Filters
Showing results (211-220 of 223) with videos related to
Page
of 23
Sort By:
Bulletin Du Cancer
|
March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]
T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2006
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients
A Aupérin, C Le Péchoux, J P Pignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study
J L Pujol, J Y Douillard, A Rivière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2017
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
M-S Tsao, G Le Teuff, F A Shepherd, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Management of unresectable non-small cell carcinoma of the lung (NSCLC)
J D Cox, T Le Chevalier, R Arriagada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
J P Delord, E Raymond, M Chaouche, et al.
The Journal of Clinical Investigation
|
December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products
H Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
W E Pierceall, K A Olaussen, V Rousseau, et al.
Lancet (London, England)
|
March 27, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
, R Arriagada, A Auperin, et al.
Bulletin Du Cancer
|
May 1, 1996
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]
T Le Chevalier, D Brisgand, J L Pujol, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 223) with videos related to
Sort By:
Page
of 23
Bulletin Du Cancer
|
March 1, 1997
[A phase II multicenter study of gemcitabine in non small cell lung cancers]
T Le Chevalier, M Gottfried, U Gatzemeier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2006
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients
A Aupérin, C Le Péchoux, J P Pignon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study
J L Pujol, J Y Douillard, A Rivière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 1, 2017
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer
M-S Tsao, G Le Teuff, F A Shepherd, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 8, 2004
Management of unresectable non-small cell carcinoma of the lung (NSCLC)
J D Cox, T Le Chevalier, R Arriagada, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies
J P Delord, E Raymond, M Chaouche, et al.
The Journal of Clinical Investigation
|
December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products
H Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 25, 2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
W E Pierceall, K A Olaussen, V Rousseau, et al.
Lancet (London, England)
|
March 27, 2010
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
, R Arriagada, A Auperin, et al.
Bulletin Du Cancer
|
May 1, 1996
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer]
T Le Chevalier, D Brisgand, J L Pujol, et al.
Page
of 23